Davis Jerel - Oct 16, 2023 Form 4 Insider Report for Turnstone Biologics Corp. (TSBX)

Signature
/s/ P. Joseph Campisi, Jr., Attorney-in-Fact
Stock symbol
TSBX
Transactions as of
Oct 16, 2023
Transactions value $
$0
Form type
4
Date filed
10/17/2023, 06:39 PM
Previous filing
Aug 11, 2023
Next filing
Jul 2, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Thirty three and thirty three one hundreds percent (33.33%) (and thirty three and thirty four one hundreds percent (33.34%) for year three) of the shares subject to the option will vest in three (3) annual installments commencing on the date of the first annual general meeting of stockholders occurring after October 12, 2023, subject to the Reporting Person's continuous service through each such vesting date.